• Mario Zanaty, Badih Daou, Nohra Chalouhi, Robert M Starke, Edgar Samaniego, Colin Derdeyn, Pascal Jabbour, and David Hasan.
• Department of Neurosurgery, University of Iowa Hospital and Clinics, Iowa City, Iowa, USA.
• World Neurosurg. 2016 Dec 1; 96: 31-35.

ObjectiveThe Pipeline Embolization Device (PED) has been used and shown to be safe under monitored anesthesia care (MAC). We present the results of the first study, to our knowledge, assessing the safety and feasibility of same-day discharge in patients undergoing treatment with the PED, using MAC.MethodsA total of 130 patients with 143 cerebral aneurysms (CAs) were identified. Patients were treated under MAC with the PED. All of the patients were counseled preoperatively about the elective nature of the procedure and the same-day discharge.ResultsThe mean age of the participants was 60.7 ± 12.12 years. Men constituted 27.69% (36/130) of the population. The number of procedures was 138. All of our patients elected to return home the same day, whereas only 6.15% (8/130) of them changed their mind in the postoperative setting and elected to stay overnight out of convenience (late discharge, patient preference, or living alone at home). Overall discharge home on the same day occurred after 90.6% of procedures (125/138) and in 91.53% (119/130) of the patients. All same-day discharges took place within 4-6 hours after the procedures. The rate of major complications was 0.75% (1/134). The mortality rate was 0%.ConclusionsPED treatment under MAC is feasible and safe. This has brought forth an era of outpatient treatment of CAs where patients are discharged home 6 hours after the procedure.Copyright © 2016 Elsevier Inc. All rights reserved.

30 keywords...

hide…